Kazia Therapeutics Shares Were Halted Late Thursday Pending An Announcement By Kazia Regarding The Proposed Trading Solely On Nasdaq And Proposed Delisting Of The Company's Securities From ASX
Portfolio Pulse from Charles Gross
Kazia Therapeutics shares were halted late Thursday pending an announcement by the company regarding the proposed trading solely on Nasdaq and proposed delisting of the company's securities from ASX.
October 06, 2023 | 8:47 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Kazia Therapeutics is considering delisting from ASX and trading solely on Nasdaq. This could potentially impact the liquidity and accessibility of the company's shares.
The proposed delisting from ASX and sole trading on Nasdaq could potentially limit the accessibility of Kazia Therapeutics' shares to certain investors, particularly those based in Australia. This could impact the liquidity of the shares. However, the actual impact will depend on the details of the announcement and the reaction of the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100